$NVCT

$19.18▲ +3.8% YTD

5 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

NVCT ▲ +3.8% - Nuvectis Pharma, Inc.

CP $19.18▲ +3.8%Nov 2, 2026 · ThinkSabio Blog

$NVCT - Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026…

News

NVCT ▲ +0.1% - Nuvectis Pharma, Inc.

CP $20.05▲ +0.1%Oct 26, 2026 · ThinkSabio Blog

$NVCT - Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated…

News

NVCT ▼ -0.2% - Nuvectis Pharma, Inc.

CP $20.13▲ -0.2%Oct 9, 2026 · ThinkSabio Blog

$NVCT - Nuvectis Pharma to Participate in the Maxim Growth Summit 2026…

News

NVCT ▼ -1.8% - Nuvectis Pharma, Inc.

CP $23.57▲ -1.8%Sep 3, 2026 · ThinkSabio Blog

$NVCT - Nuvectis Pharma To Participate in Upcoming Investor Conferences…

SEC 13D/G

NVCT - Nuvectis Pharma, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$18.96▲ 123.58%Aug 6, 2026 · ThinkSabio Blog

$NVCT SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NVCT Nuvectis Pharma, Inc. : $18.96 Sector: Healthcare | YTD: 🔼…